JACC:早产的成年个体心肌储备功能更低!

2018-03-26 MedSci MedSci原创

有研究表明早产会改变左室结构和功能,大规模流行病学调查也显示早产可以增加心衰的风险。本研究的目的旨在通过超声心动图评估早产成年个体在常规体育锻炼下的左室功能。本研究纳入了101名血压正常的成年对象,其中47名为早产(32.8 ± 3.2周),54名为足月产,并对所有研究对象进行静息和运动状态下的超声心动图检查。分析结果发现,在静息状态下与足月产对象相比,早产成年人的左室质量更大(p = 0.015

有研究表明早产会改变左室结构和功能,大规模流行病学调查也显示早产可以增加心衰的风险。本研究的目的旨在通过超声心动图评估早产成年个体在常规体育锻炼下的左室功能。本研究纳入了101名血压正常的成年对象,其中47名为早产(32.8 ± 3.2周),54名为足月产,并对所有研究对象进行静息和运动状态下的超声心动图检查。分析结果发现,在静息状态下与足月产对象相比,早产成年人的左室质量更大(p = 0.015),收缩期峰值纵向应变性降低(p = 0.038),但是射血分数相似。然而,在60%的运动强度下,早产成年对象的EF要低6.7%,在80%的运动强度下要低7.3%(p=0.004)。在40%最大运动强度下,早产成年对象的最大心输出量储备要低56%(p = 0.021)。研究结果显示,早产的成年个体在运动的刺激下左室功能相比足月产的要更低,可能解释其心衰的发生风险更高。原始出处:Odaro J et al.Physiological Stress Elicits Impaired Left Ventricular Function in Preterm-Born Adults.JACC.2018

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2019-02-01 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-04-04 考拉2177

    特别好的研究说明.特别好的app

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-04-04 考拉2177

    受教了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-28 虈亣靌

    学习了.谢谢作者分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-27 owlhealth

    不错耶.学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1853980, encodeId=a62918539800c, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Feb 01 23:35:00 CST 2019, time=2019-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053462, encodeId=a64f205346292, content=<a href='/topic/show?id=ca885398ed7' target=_blank style='color:#2F92EE;'>#成年个体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53987, encryptionId=ca885398ed7, topicName=成年个体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Sat Apr 21 04:35:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302759, encodeId=02c4302e59d6, content=特别好的研究说明.特别好的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:44:08 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302758, encodeId=928a302e5890, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/d7203757d74b0bd09c77c59b954b84a2.jpg, createdBy=29eb2235500, createdName=考拉2177, createdTime=Wed Apr 04 20:43:42 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300543, encodeId=a36f3005432c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Mar 28 19:16:08 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325777, encodeId=e2871325e77e5, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Mar 28 07:35:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300105, encodeId=4d93300105a3, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Tue Mar 27 07:15:35 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299930, encodeId=87312999309d, content=好好学习天天向上, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 26 18:06:38 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-26 忠诚向上

    好好学习天天向上

    0

相关资讯

Stroke:PPI与噻吩并吡啶

关于PPI和噻吩并吡啶交互作用的大部分研究多聚焦心血管事件,仅几项研究报道了脑血管事件。个别研究未能确定氯吡格雷联合PPI对缺血性卒中的影响。此外,由于缺乏证据(矛盾的结果),缺乏一致性意见,PPI联合噻吩并吡啶啶啶是临床的一道谜题。

CIT 2018:QFR在患者水平诊断精度荟萃分析结果首发

3月24日上午,在CIT2018 PCR at CIT专场,丹麦奥胡思大学医院(Aarhus University Hospital)Niels Holm博士首次发布“定量血流分数的诊断精度-一项来自四个前瞻性多中心临床研究的患者水平荟萃分析”。这不仅意味着国际心血管领域对QFR临床价值的认可,也意味着QFR推向临床应用又迈出了坚实的一步。

CIT 2018:新时代、新征程:从心脏介入治疗到心血管病整体防控

3月23日上午,第十六届中国介入心脏病学大会(CIT2018)开幕式和全体大会在苏州金鸡湖国际会议中心隆重召开。全球介入心脏病学意见领袖共聚一堂,由精彩示教演示、重磅研究解读、基于案例的临床热点议题讨论等组成的全体大会为大家奉上一场学术的饕餮盛宴。

JACC:LVEF降低的主动脉瓣狭窄患者预后更差

对于部分严重的主动脉瓣狭窄(AS)患者,其左室射血分数(LVEF)有所降低。本研究的目的旨在评估LVEF降低对严重AS患者预后的影响以及预测其的因素。本研究纳入了938例诊断为严重AS的患者,并对所有患者进行了一系列的心超检查,在随访的10年期间,共获得3684个(平均3个/患者)心超图像。分析结果发现,在最初的诊断中,有196例(21%)患者的LVEF<50% (35.1 ± 9.7%),对于这

JACC:LFLG主动脉瓣狭窄患者瓣膜置换术后的预后研究

近日,在国际心血管权威杂志JACC上发表了一篇临床研究,旨在评估低流量低压差主动脉瓣狭窄(LFLG-AS)患者经皮主动脉瓣置换术(TAVR)后的临床预后及左室射血分数(LVEF)的变化。本研究纳入了多中心数据库中287例接受有TAVR治疗的LFLG-AS患者,其中有234例患者在术前接受了多巴酚丁胺负荷超声心动图(DSE)检查,在患者出院时和随访1年后对所有患者进行了经胸超声心动图检查。分析结果发

JACC:ROSS手术远期预后较机械主动脉瓣换瓣术更佳

目前,ROSS手术与机械主动脉瓣换瓣手术(AVR)相比哪个预后更佳尚属未知。本研究纳入了1992年至2016年392例接受ROSS手术的患者,并与1928例接受孤立性机械AVR手术患者进行比较分析。分析结果发现,接受ROSS手术的患者更年轻,心血管危险因素更少,术后30天死亡率在两组之间无明显差异(ROSS:0.3%;机械换瓣:0.8%;p=0.5),但是ROSS手术患者的20年未经调整的生存率明